Hay, Elizabeth ACowie, PhilipMcEwan, Andrew RRoss, RuthPertwee, Roger GMacKenzie, Alasdair2020-01-092020-01-092020-01-01Hay, E A, Cowie, P, McEwan, A R, Ross, R, Pertwee, R G & MacKenzie, A 2020, 'Disease associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue specific activity of the cannabinoidâ1 receptor gene promoter; implications for cannabinoid pharmacogenetics ', Human Mutation, vol. 41, no. 1, pp. 291-298. https://doi.org/10.1002/humu.239311059-7794https://hdl.handle.net/2164/13486EH was funded by Medical Research Scotland (PhD-719-2013) and GW Pharmaceuticals. AMcE was funded by BBSRC project grant (BB/N017544/1). PB and DW are funded by the Scottish Government Rural and Environment Science and Analytical Services Division to the Rowett Institute. The authors declare no conflicts of interest.81304614engSDG 3 - Good Health and Well-beingDisease associated polymorphismsCannabinoid-1 receptorgene regulationtissue specificpromoterenhancerCB1 agoniststranscription factorChromatin immunoprecipitationCannabinoid pharmacogeneticsSYSTEMcannabinoid pharmacogeneticsWin55CTCFFOSAP-1212-2chromatin immunoprecipitationdisease-associated polymorphisms cannabinoid-1 receptorTRANSCRIPTIONAL REGULATIONQH426 GeneticsGenetics(clinical)GeneticsOtherPhD-719-2013Biotechnology and Biological Sciences Research Council (BBSRC)BB/N017544/1Rural and Environmental Science and Analytical Services (RESAS)QH426Disease associated polymorphisms within the conserved ECR1 enhancer differentially regulate the tissue specific activity of the cannabinoidâ1 receptor gene promoter; implications for cannabinoid pharmacogeneticsJournal article10.1002/humu.23931http://www.scopus.com/inward/record.url?scp=85074761900&partnerID=8YFLogxK411